Roy W. Beck

Q: What Schools Are Affiliated With Roy W. Beck

Roy W. Beck is affiliated with the following schools: University of South Florida

Roy W. Beck's AcademicInfluence.com Rankings

Roy W. Beck

Medical

#1509

World Rank

#1854

Historical Rank

Epidemiology

#221

World Rank

#236

Historical Rank

medical Degrees

Download Badge

Medical

Roy W. Beck's Degrees

Masters Public Health University of South Florida

Why Is Roy W. Beck Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roy W. Beck's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) (1526)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. (2000) (1503)
International Consensus on Use of Continuous Glucose Monitoring (2017) (1129)
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. (2015) (1034)
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry (2015) (1021)
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis (1992) (973)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. (2019) (966)
Continuous glucose monitoring and intensive treatment of type 1 diabetes. (2008) (817)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial (2017) (724)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. (2016) (691)
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. (2015) (566)
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. (1993) (566)
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. (2011) (531)
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. (2007) (518)
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. (2001) (500)
Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. (2008) (469)
The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. (1999) (451)
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. (2007) (440)
Randomized trial of treatment of amblyopia in children aged 7 to 17 years. (2005) (439)
Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants (2013) (434)
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials (2018) (424)
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. (2003) (394)
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. (2003) (394)
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. (2009) (393)
A randomized trial of patching regimens for treatment of moderate amblyopia in children. (2003) (391)
The T1D Exchange clinic registry. (2012) (379)
Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines (2013) (368)
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. (2012) (357)
The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes (2009) (355)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. (2019) (355)
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. (2003) (336)
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. (1992) (335)
Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. (1987) (331)
A randomized trial of atropine vs patching for treatment of moderate amblyopia in children (2002) (328)
The amblyopia treatment study visual acuity testing protocol. (2001) (299)
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring (2018) (297)
Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. (1998) (284)
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment (2009) (271)
Optic neuritis treatment trial. One-year follow-up results. (1993) (270)
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes (2009) (270)
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry (2014) (269)
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial. (2017) (267)
Treatment of anisometropic amblyopia in children with refractive correction. (2006) (262)
Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. (2013) (261)
The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading (2017) (253)
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). (2013) (241)
Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes (2009) (241)
Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. (2012) (240)
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. (2007) (237)
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. (2005) (231)
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c (2019) (222)
Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. (2001) (218)
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (2018) (217)
Optic disc structure in anterior ischemic optic neuropathy. (1984) (217)
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial (2018) (215)
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. (2004) (215)
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. (2004) (212)
The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. (1994) (212)
Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. (1993) (208)
Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry (2013) (204)
Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes (2015) (204)
Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries (2015) (198)
A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years (2012) (192)
The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial (2017) (185)
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. (2017) (182)
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes (2017) (180)
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. (2008) (178)
Cortical blindness: Etiology, diagnosis, and prognosis (1987) (176)
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes (2014) (175)
A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. (2006) (174)
Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry (2016) (170)
Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany (2015) (168)
The effect of donor age on corneal transplantation outcome results of the cornea donor study. (2008) (164)
Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. (2008) (161)
The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. (2000) (159)
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. (2007) (159)
Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. (1993) (154)
Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. (1997) (153)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. (2020) (152)
Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries (2014) (151)
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial (2018) (150)
Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes (2010) (149)
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. (2005) (148)
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial (2018) (148)
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control. (2018) (144)
A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes (2014) (143)
Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. (2015) (142)
Risk of amblyopia recurrence after cessation of treatment. (2004) (141)
The clinical profile of moderate amblyopia in children younger than 7 years (2002) (141)
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. (2006) (139)
The 5-year risk of MS after optic neuritis (1998) (138)
Alterations in White Matter Structure in Young Children With Type 1 Diabetes (2014) (138)
Continuous glucose monitoring in children with type 1 diabetes. (2007) (134)
Visual acuity as an outcome measure in clinical trials of retinal diseases. (2007) (132)
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. (2015) (132)
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study (2005) (131)
Recipient risk factors for graft failure in the cornea donor study. (2009) (131)
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis (2015) (130)
Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. (2016) (130)
A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. (2010) (130)
Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. (2005) (130)
Evaluation of factors affecting CGMS calibration. (2006) (128)
A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter. (1985) (127)
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. (2008) (126)
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. (2020) (126)
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. (2020) (123)
Contrast sensitivity and other vision tests in the optic neuritis treatment trial. (1996) (123)
RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION (2011) (123)
Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses (2002) (122)
Oculomasticatory myorhythrma: A unique movement disorder occurring in Whipple's disease (1986) (122)
Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. (2010) (121)
Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. (2003) (119)
A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. (2005) (118)
Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes (2009) (118)
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery. (2017) (117)
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (2013) (117)
Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study (2017) (117)
Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. (1993) (116)
Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy (2014) (115)
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. (2011) (114)
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. (2009) (113)
Factors associated with corneal graft survival in the cornea donor study. (2015) (112)
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes (2015) (110)
Neuroanatomical Correlates of Dysglycemia in Young Children With Type 1 Diabetes (2013) (110)
FACTORS ASSOCIATED WITH VISUAL ACUITY OUTCOMES AFTER VITRECTOMY FOR DIABETIC MACULAR EDEMA: Diabetic Retinopathy Clinical Research Network (2010) (109)
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial (2021) (109)
Visual function 5 years after optic neuritis: Experience of the optic neuritis treatment trial (1997) (108)
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. (2008) (108)
Glycemic control and excess mortality in type 1 diabetes. (2015) (107)
Donor age and factors related to endothelial cell loss 10 years after penetrating keratoplasty: Specular Microscopy Ancillary Study. (2013) (107)
Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty. (2010) (106)
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. (2008) (105)
Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. (2011) (105)
Deficits in visual function after resolution of optic neuritis. (1987) (105)
High success rates of sedation-free brain MRI scanning in young children using simple subject preparation protocols with and without a commercial mock scanner–the Diabetes Research in Children Network (DirecNet) experience (2014) (104)
Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia (2014) (104)
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. (2010) (103)
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study (2017) (102)
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. (2013) (101)
A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experience (2014) (101)
Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. (2013) (100)
Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. (2013) (98)
Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals (2010) (98)
Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator) (2008) (98)
Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. (2009) (98)
A COMPUTERIZED METHOD OF VISUAL ACUITY TESTING: ADAPTATION OF THE EARLY TREATMENT OF DIABETIC RETINOPATHY STUDY TESTING PROTOCOL (2003) (97)
Multinational Home Use of Closed-Loop Control Is Safe and Effective (2016) (96)
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. (2021) (96)
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. (2008) (95)
Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. (2008) (94)
Is there a racial difference in physiologic cup size? (1985) (94)
Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. (1993) (94)
Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies. (1990) (93)
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium (2016) (93)
Neurologic impairment 10 years after optic neuritis. (2004) (91)
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes (2016) (91)
Radiation-induced optic neuropathy: a magnetic resonance imaging study. (1991) (91)
Advances in technology for management of type 1 diabetes (2019) (90)
Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry (2013) (89)
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study (2015) (88)
Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. (2003) (87)
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. (2013) (87)
The natural history of acute traumatic sixth nerve palsy or paresis. (1998) (86)
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. (2009) (85)
15-Year Outcomes Following Threshold Retinopathy of Prematurity Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (2005) (84)
The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. (2013) (82)
Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study (2015) (82)
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. (2010) (80)
Specular Microscopy Ancillary Study Methods for Donor Endothelial Cell Density Determination of Cornea Donor Study Images (2006) (78)
The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis (1998) (78)
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. (2011) (77)
Satisfaction with continuous glucose monitoring in adults and youths with type 1 diabetes (2013) (77)
Corticosteroids for treating optic neuritis. (2012) (77)
An evaluation of image quality and accuracy of eye bank measurement of donor cornea endothelial cell density in the Specular Microscopy Ancillary Study. (2005) (77)
Baseline Donor Characteristics in the Cornea Donor Study (2005) (76)
Cognitive Functioning in Young Children with Type 1 Diabetes (2014) (75)
Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes (2012) (75)
Quality-of-Life Measures in Children and Adults With Type 1 Diabetes (2010) (74)
Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. (2008) (73)
The Amblyopia Treatment Index. (2001) (73)
Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. (2006) (72)
Design, methods, and conduct of the Optic Neuritis Treatment Trial. (1993) (72)
A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. (2005) (72)
Treatment of strabismic amblyopia with refractive correction. (2007) (72)
Severe hypoglycemia rates are not associated with HbA1c: a cross‐sectional analysis of 3 contemporary pediatric diabetes registry databases (2017) (71)
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. (2017) (71)
Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. (2002) (70)
Pain in Anterior Ischemic Optic Neuropathy (1995) (70)
FreeStyle Navigator Continuous Glucose Monitoring System Use in Children With Type 1 Diabetes Using Glargine-Based Multiple Daily Dose Regimens (2008) (70)
Resolution of congenital nasolacrimal duct obstruction with nonsurgical management. (2012) (69)
Orbital emphysema as an ophthalmologic emergency. (1984) (68)
Panretinal photocoagulation for proliferative diabetic retinopathy. (2011) (68)
Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. (2000) (67)
Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial (1994) (66)
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. (2016) (66)
Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections (2000) (66)
Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections (2016) (66)
The Optic Neuritis Treatment Trial. (1988) (66)
The optic neuritis treatment trial: three-year follow-up results. (1996) (65)
Factors Associated With Microalbuminuria in 7,549 Children and Adolescents With Type 1 Diabetes in the T1D Exchange Clinic Registry (2013) (65)
Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. (2007) (64)
Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes (2013) (64)
Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. (1986) (64)
Depression in Adults in the T1D Exchange Clinic Registry (2014) (63)
Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple‐daily injection therapy (2009) (63)
Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics (2018) (63)
Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study. (2019) (62)
A randomized trial of increasing patching for amblyopia. (2013) (62)
Predictors of nonrecovery in acute traumatic sixth nerve palsy and paresis. (2001) (61)
Acute ischemic optic neuropathy in severe preeclampsia. (1980) (61)
Persistence of Individual Variations in Glycated Hemoglobin (2011) (61)
The Optic Neuritis Treatment Trial: Three-Year Follow-up Results (1995) (61)
Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial. (2009) (60)
The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathy. (2001) (60)
Donor Risk Factors for Graft Failure in the Cornea Donor Study (2009) (60)
Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). (1993) (59)
Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. (2007) (59)
Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. (1996) (58)
Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes (2011) (58)
Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index (2016) (58)
To mask or not to mask. (2009) (58)
Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. (2013) (56)
HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings. (2020) (56)
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes (2011) (56)
Observational study of subclinical diabetic macular edema (2010) (55)
Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes (2018) (55)
Corneal Graft Rejection 10 Years After Penetrating Keratoplasty in the Cornea Donor Study (2014) (52)
Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. (1996) (52)
Glycemic Monitoring and Management in Advanced Chronic Kidney Disease. (2020) (51)
A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System (2020) (51)
Blunted Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents With Well-Controlled Type 1 Diabetes (2009) (50)
Effect of Donor and Recipient Factors on Corneal Graft Rejection (2012) (50)
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS (2000) (49)
A randomized trial of levodopa as treatment for residual amblyopia in older children. (2015) (48)
Accuracy and Precision of the Axis-Shield Afinion Hemoglobin A1c Measurement Device (2012) (48)
Effect of Cornea Preservation Time on Success of Descemet Stripping Automated Endothelial Keratoplasty: A Randomized Clinical Trial (2017) (48)
The 5-year risk of MS after optic neuritis (1997) (48)
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. (2014) (47)
Structural factors in the pathogenesis of ischemic optic neuropathy. (1984) (47)
Clinical Profile and Early Surgical Complications in the Cornea Donor Study (2006) (46)
Corneal Endothelial Cell Loss 3 Years After Successful Descemet Stripping Automated Endothelial Keratoplasty in the Cornea Preservation Time Study: A Randomized Clinical Trial (2017) (46)
Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections (2017) (45)
A randomized trial comparing part-time patching with observation for children 3 to 10 years of age with intermittent exotropia. (2014) (45)
Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. (2005) (45)
Retinal nerve fiber layer thickness in amblyopic eyes. (2007) (45)
Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes (2011) (44)
Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. (1995) (43)
What we have learned from the Optic Neuritis Treatment Trial. (1995) (43)
Baseline factors related to endothelial cell loss following penetrating keratoplasty. (2011) (43)
Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry (2017) (43)
Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. (2004) (42)
The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5‐anhydroglucitrol, and continuous glucose monitoring (2011) (42)
Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries. (2016) (42)
Use of continuous glucose monitoring as an outcome measure in clinical trials. (2012) (42)
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. (2014) (42)
Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System (2014) (41)
The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. (2003) (41)
The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group. (1992) (40)
The effect of donor diabetes history on graft failure and endothelial cell density 10 years after penetrating keratoplasty. (2015) (40)
Visual Symptoms After Optic Neuritis: Results from the Optic Neuritis Treatment Trial (1997) (40)
A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. (2012) (38)
Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes (2017) (38)
Cerebrospinal fluid in acute optic neuritis (1996) (38)
Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. (2013) (38)
Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months (2016) (37)
Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes (2007) (36)
Contrast sensitivity measurements in acute and resolved optic neuritis. (1984) (36)
Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis (2014) (36)
Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall (2018) (36)
Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. (2013) (35)
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age. (2008) (35)
Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. (1983) (34)
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research. (2009) (34)
CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes (2015) (34)
The effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection. (2009) (33)
Visual function at baseline and 1 month in acute optic neuritis (2007) (33)
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial. (2020) (33)
Continuous glucose monitoring in type 1 diabetes (2013) (32)
Randomized trial to evaluate combined patching and atropine for residual amblyopia. (2011) (32)
The Optic Neuritis Treatment Trial: Putting the Results in Perspective (1995) (32)
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis (2014) (32)
Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. (2005) (32)
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. (2020) (32)
OCULAR SIDE EFFECTS ASSOCIATED WITH PERIBULBAR INJECTIONS OF TRIAMCINOLONE ACETONIDE FOR DIABETIC MACULAR EDEMA (2011) (31)
The effect of amblyopia therapy on ocular alignment. (2005) (31)
Endothelial morphometric measures to predict endothelial graft failure after penetrating keratoplasty. (2013) (31)
Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years. (2010) (31)
Continuous glucose monitoring pilot in low-income type 1 diabetes patients. (2013) (31)
Bilateral idiopathic inflammation of the optic nerve sheaths. Light and electron microscopic findings. (1989) (31)
Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry. (2018) (30)
Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes (2016) (30)
Corneal Thickness as a Predictor of Corneal Transplant Outcome (2013) (30)
Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes (2013) (29)
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma (2016) (29)
Clinical research in pediatric ophthalmology: The Pediatric Eye Disease Investigator Group (2002) (29)
Challenges for outpatient closed loop studies: how to assess efficacy. (2013) (29)
The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set. (2019) (29)
Diabetes Research in Children Network: Availability of Protocol Data Sets (2007) (29)
Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. (2009) (29)
Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study. (2001) (29)
Control of familywise errors in multiple endpoint assessments via stepwise permutation tests. (1996) (28)
Is donor age an important determinant of graft survival? (1999) (28)
Vigabatrin-associated retinal cone system dysfunction (1998) (28)
GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. (2004) (28)
Corticosteroids for treating optic neuritis. (2007) (27)
Office probing for treatment of nasolacrimal duct obstruction in infants. (2014) (27)
The Pelli-Robson letter chart: normative data for young adults (1993) (26)
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. (2000) (26)
Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time in Range All We Need? (2020) (26)
Visual acuity testing using autorefraction or pinhole occluder compared with a manual protocol refraction in individuals with diabetes. (2011) (26)
Comparison of the amblyopia treatment study HOTV and the electronic-early treatment of diabetic retinopathy study visual acuity protocols in amblyopic children aged 5 to 11 years. (2009) (26)
Functional disease in neuro-ophthalmology. (1983) (26)
Hypoglycemia in Older Adults with Type 1 Diabetes. (2016) (25)
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study (2017) (25)
Post-decompression optic neuropathy. (1985) (24)
Hemoglobin A 1 c andMean Glucose in PatientsWith Type 1 Diabetes Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial (2011) (24)
Corticosteroids for treating optic neuritis. (2015) (23)
Recovery from severe visual loss in optic neuritis. (1993) (23)
Anterior ischaemic optic neuropathy: recurrent episodes in the same eye. (1983) (23)
Decreased visual acuity from optic disc drusen. (1985) (23)
Randomized Controlled Trial of Mobile Closed-Loop Control (2020) (23)
The Effects of Aerobic Exercise on Glucose and Counter- regulatory Hormone Concentrations in Children with Type 1 Diabetes The Diabetes Research in Children Network (DirecNet) Study Group * (2008) (22)
A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in children. (2006) (21)
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. (2000) (21)
Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate. (2011) (21)
Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants (2016) (21)
Contrast sensitivity following amblyopia treatment in children. (2009) (20)
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes (2020) (20)
Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual β-Cell Function (2012) (20)
Neuroretinitis in childhood. (1989) (20)
Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry (2017) (19)
Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes (2017) (19)
Lived experience of advanced hybrid closed-loop versus hybrid closed loop: patient-reported outcomes and perspectives. (2021) (19)
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels (2018) (19)
Predictive hyperglycemia and hypoglycemia minimization: In‐home double‐blind randomized controlled evaluation in children and young adolescents (2018) (19)
A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction. (2013) (18)
Adults with type 1 diabetes: Partner relationships and outcomes (2017) (18)
Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema. (2012) (18)
Cataract progression in India (1997) (18)
Marked Increases in CGM Use Has Not Prevented Increases in HbA1c Levels in Participants in the T1D Exchange (T1DX) Clinic Network (2018) (18)
Iatrogenic Horner's syndrome secondary to chest tube thoracostomy. (1983) (17)
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. (2022) (17)
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin (2021) (17)
Involvement of the optic chiasm, optic tract and geniculo-calcarine visual system in multiple sclerosis. (1983) (17)
An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HBALC. (2021) (17)
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis. (2013) (17)
Body mass index changes in youth in the first year after type 1 diabetes diagnosis. (2015) (16)
Atonic pupil after cataract surgery. (1989) (16)
The relationship between neuropsychological assessment, numeracy, and functional status in older adults with type 1 diabetes (2017) (16)
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial (2020) (16)
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections (2018) (16)
Persistently high glucose levels in young children with type 1 diabetes (2016) (16)
Monocular oral reading performance after amblyopia treatment in children. (2008) (16)
The changing role of MR imaging in the evaluation of acute optic neuritis. (1994) (16)
Comparison of atropine and patching treatments: Author reply (2004) (15)
Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years (2013) (15)
Low‐fat vs. high‐fat bedtime snacks in children and adolescents with type 1 diabetes (2008) (15)
C‐peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry (2016) (15)
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice (2022) (15)
Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring (2020) (14)
Uveitis Associated With Topical β-Blockers (1996) (14)
Does Levodopa improve visual function in NAION? (2000) (14)
A mathematical model to predict endothelial cell density following penetrating keratoplasty with selective dropout from graft failure. (2014) (14)
Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. (2021) (13)
Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears. (2022) (13)
More time in glucose range during exercise days than sedentary days in adults living with type 1 diabetes. (2020) (13)
Treatment of severe amblyopia with atropine: Results from 2 randomized clinical trials. (2009) (13)
Recent advances in the treatment of amblyopia. (2004) (13)
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System. (2021) (13)
Patient Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed Loop Trial. (2021) (13)
Outcome Measures for Outpatient Hypoglycemia Prevention Studies (2011) (13)
Pattern flash visual evoked potentials in patients with homonymous hemianopia (2004) (12)
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy (2017) (12)
Sample size for a clinical trial: why do some trials need only 100 patients and others 1000 patients or more? (2006) (12)
Optic disc edema in the presumed ocular histoplasmosis syndrome. (1984) (12)
Bilateral optic nerve sheath enlargement. (1986) (11)
Treatment of Graves' ophthalmopathy. (1990) (11)
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. (2022) (11)
Iris ischemia following surgery on two rectus muscles. (1985) (11)
The burgeoning public health impact of diabetes: the role of the ophthalmologist. (2011) (11)
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data (2019) (11)
Cavernous sinus syndrome as the initial manifestation of multiple myeloma. (1987) (11)
Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy (2002) (11)
Downloading Diabetes Device Data: Empowering Patients to Download at Home to Achieve Better Outcomes. (2015) (10)
Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes. (2015) (10)
Changes in beta cell function during the proximate post‐diagnosis period in persons with type 1 diabetes (2016) (10)
Challenges and Future Directions of the T1D Exchange Clinic Network and Registry (2013) (10)
Third nerve palsy as a presenting sign of acquired immune deficiency syndrome. (1987) (10)
Relative accuracy of the BD Logic and FreeStyle blood glucose meters. (2007) (9)
Conjunctival, corneal involvement accompanying erosive-ulcerative blepharitis. (1981) (9)
Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin. (2007) (9)
Internuclear ophthalmoplegia after head trauma. (1981) (9)
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. (2022) (9)
Photodynamic therapy for age-related macular degeneration. (2004) (8)
Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. (1992) (8)
The T1D Exchange Clinic Network and Registry: 10 Years of Enlightenment on the State of Type 1 Diabetes in the United States. (2019) (8)
Real-world, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes using the MiniMed 670G Hybrid Closed Loop System. (2021) (8)
The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. (1996) (8)
Impact of the Cornea Donor Study on Acceptance of Corneas From Older Donors (2012) (8)
Neuro-Ophthalmology: A Problem-Oriented Approach (1987) (8)
No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year (2016) (8)
Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes (2020) (8)
Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes (2008) (8)
Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry (2018) (8)
Registration of clinical trials. (2005) (7)
Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702–2709 (2015) (7)
A web-based study of the relationship of duration of insulin pump infusion set use and fasting blood glucose level in adults with type 1 diabetes. (2015) (7)
Plaque causing homonymous hemianopsia in multiple sclerosis identified by computed tomography. (1982) (7)
Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply. (2021) (7)
Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data (2020) (7)
Effects of dilation on electronic-ETDRS visual acuity in diabetic patients. (2009) (7)
Is donor age an important determinant of graft survival? (2000) (7)
Journal editors should not require complete data sets for independent scrutiny. (2000) (6)
The SKILL Card Test in Optic Neuritis: Experience of the Optic Neuritis Treatment Trial (2001) (6)
Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197–1204 (2015) (6)
Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin. (2021) (6)
Retinitis pigmentosa. A mimic of neurologic disease. (1987) (6)
Traumatic orbital encephalocele. (1989) (6)
Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin delivery. (2014) (6)
Accuracy and Precision of the Axis-Shield Afinion Hemoglobin A 1 c Measurement Device (2012) (6)
Treatment of Bilateral Refractive Amblyopia in Children 3-9 Years Old (2007) (6)
Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange. (2018) (6)
Uveitis associated with topical beta-blockers. (1996) (6)
Laser photocoagulation for central serous retinopathy. (1997) (5)
Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes? (2021) (5)
MRI in Optic Neuritis-Reply (1989) (5)
Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study (2021) (5)
A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes. (2022) (5)
The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. (2020) (5)
Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic (2004) (5)
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. (2022) (5)
Herpetic eye disease study. You can help. (1996) (5)
Assessing Mealtime Macronutrient Content: Patient Perceptions versus Expert Analyses via a Novel Phone App. (2020) (5)
Internuclear ophthalmoplegia following head injury. (1980) (5)
Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks? (2020) (5)
Evaluation of masking study participants to intravitreal injections in a randomized clinical trial. (2012) (5)
The neuro-ophthalmic examination. (1983) (5)
Sustained increases in intraocular pressure during strabismus surgery. (1986) (5)
Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280 (2018) (5)
Continuous glucose monitoring in type 1 diabetes mellitus (2009) (5)
Comparison of the ONTT intravenous group and the CHAMPS placebo group. (2001) (4)
Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial (2020) (4)
Adults with Type 1 Diabetes (2015) (4)
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes. (2022) (4)
Remote clinic/patient monitoring for multicenter trials (1996) (4)
Automated perimetry: principles and practice. (1986) (4)
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents (2022) (4)
What to tell the patient with optic neuritis about multiple sclerosis. (1991) (4)
VIGABATRIN-ASSOCIATED RETINAL CONE SYSTEM DYSFUNCTION. AUTHORS' REPLY (1998) (4)
ASPIRIN USE AND THE PREVENTION OF ACUTE ISCHEMIC CRANIAL NERVE PALSY (2000) (4)
Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study (2020) (4)
Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity. (2021) (4)
Glycaemic Control and Acute Complications in European Children, Adolescents, and Young Adults With Type 1 Diabetes in the Teens Study (2014) (3)
Ocular Deviations after Head Injury (1985) (3)
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. (2022) (3)
CHEIROARTHROPATHY: A COMMON DISORDER IN PATIENTS IN THE T1D EXCHANGE. (2019) (3)
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Reply. (2020) (3)
Amblyopia. Current clinical studies. (2001) (3)
Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Reply. (2020) (3)
Advances in the treatment of carotid cavernous fistulas. (1986) (3)
Continuous Glucose Monitoring Profiles in Healthy, Nondiabetic Young Children (2022) (3)
A Pilot Study of levodopa as treatment for residual amblyopia in children 8 to 17 years old (2010) (3)
The optic neuritis treatment trial: implications for clinicians. (1995) (3)
A PHASE II STUDY OF IV METHYLPREDNISOLONE IN SECONDARY PROGRESSIVE MS. AUTHORS' REPLY (1999) (3)
Orbital involvement in mycosis fungoides. (1984) (3)
The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait. (2016) (3)
Reporting the results of randomized clinical trials: a priority of Archives of Ophthalmology. (2004) (3)
Postgadolinium enhancement of a compressive neuropathy of the optic nerve. (1995) (3)
Patching regimens: author reply (2004) (3)
Corticosteroids for treating optic neuritis (Review) (2012) (3)
Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve (2021) (3)
The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes. (2022) (2)
836-P: Cannabis Use in Adults with Type 1 Diabetes (T1D) Is Associated with Poor Glycemic Control and Increased Risk for Diabetic Ketoacidosis (DKA) (2019) (2)
Optic neuritis or anterior ischemic optic neuropathy? (1992) (2)
Effect of a growth hormone receptor antagonist on proliferative diabetic retinopathy. Authors' reply (2002) (2)
A study to assess initiation of CGM outside of a clinic (2020) (2)
Function of the GlucoWatch G2 Biographer during exercise. (2005) (2)
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607–615 (2020) (2)
Optic nerve sheath fenestration for anterior ischemic optic neuropathy? The answer is in. (1995) (2)
The Optimal Duration of a Run-in Period to Initiate Continuous Glucose Monitoring for a Randomized Trial. (2022) (2)
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (2017) (2)
Response to Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177–e178 (2017) (2)
Primary Treatment of Nasolacrimal Duct Obstruction with Nasolacrimal Duct Intubation in Children Less than Four Years (2008) (2)
Comparison of Graft Outcomes Reusing Original Intermediate-Term Cold Storage Solution for Entire Corneal Donor Storage Period With Exchanged Fresh Storage Solution After Donor Preparation in the Cornea Preservation Time Study (2022) (2)
A randomized trial comparing cost-effectiveness of immediate office probing versus observation with deferred facility probing for unilateral congenital nasolacrimal duct obstruction (2012) (2)
Corticosteroids and optic neuritis (1993) (2)
Amblyopia in Children Aged 7 to 17 Years—Reply (2006) (2)
Assessment of the Glucose Management Indicator Using Different Sampling Durations. (2022) (1)
TREATMENT OF OPTIC NEURITIS. AUTHOR'S REPLY (1993) (1)
Sample sizes for clinical trials. Author's reply (2007) (1)
Corneal astigmatism associated with aniridia. (1982) (1)
Cambridge Hybrid Closed-Loop Algorithm in Children and Adolescents with Type 1 Diabetes: A Multicentre 6-Month Randomised Trial (2021) (1)
DESIGN, METHOD, AND CONDUCT OF OPTIC NEURITIS TREATMENT TRIAL (1993) (1)
Title: Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children with Type 1 Diabetes: Association with Hyperglycemia Short Title: Brain Changes in Young Children with T1D (2014) (1)
Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002—1009 (2018) (1)
1001-P: Do-It-Yourself (DIY) Loop Is Associated with Psychosocial Benefits (2020) (1)
Non-Adjunctive Use of CGM-The End of Fingersticks? (2019) (1)
Resolution of nasolacrimal duct obstruction with nonsurgical management in children 6 to <10 months old (2012) (1)
The Office for Human Research Protections and the NIH. (2003) (1)
Computerized optic disk imaging techniques. (1986) (1)
Continuous Glucose Monitors for Insulin Dosing. (2018) (1)
Exceptional Usability of Tandem t:slim X2 with Basal-IQ Predictive Low-Glucose Suspend (PLGS)—The PROLOG Study (2018) (1)
A Comparison of Two Hybrid Closed-Loop Systems in Adolescents and Young Adults with Type 1 Diabetes: A Multicenter Randomized Crossover Trial (2020) (1)
Monocular Oral Reading Performance Following Amblyopia Treatment in Children (2009) (1)
Insulin pump treatment in children with type 1 diabetes : a study of patient preferences , satisfaction and metabolic control (1)
JAMA Ophthalmology Publication Policies and Procedures: Fresh Start for a New Year (2014) (1)
Retina, The Journal of Retinal and Vitreous Diseases 2016 Scientific Reviewers. (2017) (1)
034: Treatment of severe amblyopia with atropine: Results from two randomized clinical trials (2009) (1)
Optic nerve head drusen. (1984) (1)
Remote clinic/patient monitoring for multicenter trials. Optic Neuritis Study Group. (1996) (1)
Risk factors for postoperative endophthalmitis. (1992) (0)
Potential bias in amblyopia treatment study: Reply (2009) (0)
Image Quality and Accuracy of Eye Bank Measurement of Donor Cornea Endothelial Cell Density in the Cornea Donor Study (2003) (0)
DKA During Diabetes Therapy: Multinational Comparison with 59 191 Pediatric Patients from England, Wales, The United States, Austria and Germany (2014) (0)
Accuracy of Three Commercial Home-Use HbA1c Tests. (2022) (0)
A New PC-based Method of Measuring Visual Acuity in Clinical Trials (2002) (0)
The Phakomatoses (1985) (0)
Effect of a growth hormone receptor antagonist on proliferative diabetic retinopathy [1] (multiple letters) (2002) (0)
Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-loop Systems. (2022) (0)
1304-P: Glycemic Trends in a Hockey Camp for Youth with Type 1 Diabetes (T1D) (2020) (0)
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. (2022) (0)
Retina, The Journal of Retinal and Vitreous Diseases 2017 Scientific Reviewers. (2018) (0)
CLINICALLY DEFINITE MULTIPLE SCLEROSIS FOLLOWING OPTIC NEURITIS. AUTHORS' REPLY (1997) (0)
333-OR: Assessing Mealtime Macronutrient Content: Patient Perceptions vs. Expert Analyses via a Novel Phone App (2019) (0)
741-P: More Time-in-Range during Days with Structured Exercise vs. Sedentary Days in Adults with Type 1 Diabetes (2019) (0)
32-LB: Interstitial Glucose Levels during Exercise in Persons with and without Type 1 Diabetes (2021) (0)
The Pediatric Eye Disease Investigator Group Report May Be Too Optimistic About Efficacy of Treatment: In Reply (2004) (0)
871-P: Baseline Time-in-Range Association with Glycemic Improvement in Adults with Type 1 Diabetes (T1D) (2020) (0)
Visual Fields in Optic Neuritis-Reply (1993) (0)
ANNUAL REVIEWERS LIST (2009) (0)
Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis in Patients with Monosymptomatic Presentations of Optic Neuritis, Brainstem Syndromes or Myelopathy (1996) (0)
A Comparison of CGM Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes. (2022) (0)
694-P: Effect of Exercise on Sleep and Nocturnal Glucose in Type 1 Diabetes (T1D) (2020) (0)
Relative inaccuracy of the alcnow in children with type 1 diabetes (2007) (0)
101-LB: Eighteen-Month Use of Closed-Loop Control (CLC): A Randomized, Controlled Trial (2020) (0)
217-OR: Islet Transplantation vs. Standard of Care for Type 1 Diabetes Complicated by Severe Hypoglycemia from the Collaborative Islet Transplant Registry (CITR) and T1D Exchange (T1DX) Registry (2019) (0)
Uveitis as a Presenting Feature of Autoimmune Hepatitis (2009) (0)
A New Symptom Survey and Quality of Life Questionnaire for Nasolacrimal Duct Obstruction (2005) (0)
Patching Regimens for Amblyopia: Author reply (2005) (0)
687-P: Support Vector Regression Model Predicts Glucose Changes during Exercise in Type 1 Diabetes (2020) (0)
Letter to the EditorAuthor Reply (2007) (0)
102-LB: Cross-Study Comparisons Done Right: An Illustration Using Two Pivotal Trials of Closed-Loop Systems (2020) (0)
Amaurosis fugax: controversies in management. (1986) (0)
Eye movements in patients with absent voluntary horizontal gaze (1985) (0)
Treatment of Amblyopia With Refractive Correction Alone (2006) (0)
A Comparison of Post-Prandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System vs 670G. (2022) (0)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults Using Multiple Daily Insulin Injections (2017) (0)
How Much Should We Editorialize?-Reply (1994) (0)
The obesity epidemic in 32,936 youth with type 1 diabetes (T1D) in the German/Austrian DPV and US T1D Exchange (T1DX) registries (2015) (0)
Diabetic Macular Edema Following Panretinal Photocoagulation. Authors' reply (2010) (0)
Potential Bias in Amblyopia Treatment Study. Authors' reply (2009) (0)
In reply [8] (2006) (0)
Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Children and Adolescents: A Multicenter Prospective Study (2018) (0)
Treatment of optic neuritis (1993) (0)
Outcome Measures. Authors' reply (2008) (0)
The Idiopathic Intracranial Hypertension Treatment Trial : A Long-Time Coming but (2016) (0)
Atropine Regimens for Amblyopia: Author reply (2005) (0)
Optic Neuritis Treatment Trial Study-Reply (1994) (0)
Observational study of subclinical diabetic macular edema (2012) (0)
Restrictions on Use of Prescribing Data for Drug Promotion (2012) (0)
Prepublication Blackout in the Optic Neuritis Treatment Trial-Reply (1994) (0)
717-P: Real-World, Patient-Reported Data on Training and Use of 670G Hybrid Closed-Loop (HCL) among Children and Adults with Type 1 Diabetes (T1D) (2021) (0)
Phase 1 dose-finding study of bevacizumab for retinopathy of prematurity (2017) (0)
53P A system of remote clinic monitoring for multi-center trials (1994) (0)
Volunteering for a Clinical Trial: A Question and Answer Guide (2006) (0)
In reply [2] (2006) (0)
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis (1997) (0)
81-LB: Daily Tracking of Hemoglobin A1C through Personalized Glycation Model (2020) (0)
Visual Loss in Eclampsia (1981) (0)
Diabetic Macular Edema Following Panretinal Photocoagulation--Reply (2010) (0)
100-LB: Closed-Loop Control Reduces Hypoglycemia without Increased Hyperglycemia in Subjects with Increased Prestudy Hypoglycemia: Results from the iDCL DCLP3 Randomized Trial (2020) (0)
Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears: Response to Letter to Editor. (2022) (0)
Emphasizing Optimal Diabetes Management for All Races/Ethnicities, but Not Race/Ethnicity-Specific Cut Points for Hemoglobin A1c. (2019) (0)
The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathy: Author reply (2002) (0)
Authors/Writing Committee (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roy W. Beck?

Roy W. Beck is affiliated with the following schools:

University of South Florida